Evidence map›Paper›PMID 28581469›Full record

Trial reportBone marrow transplantation2017

Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database.

A Necchi, S Lo Vullo, G Rosti, M Badoglio, P Giannatempo, D Raggi, S Secondino, L Mariani, F Lanza, P Pedrazzoli

Abstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

A NecchiFondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
S Lo VulloFondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
G RostiFondazione IRCCS Policlinico San Matteo, Pavia, Italy.
M BadoglioEBMT Study Office, EBMT, Paris, France.
P GiannatempoFondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
D RaggiFondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
S SecondinoFondazione IRCCS Policlinico San Matteo, Pavia, Italy.
L MarianiFondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
F LanzaHospital of Ravenna, Ravenna, Italy.
P PedrazzoliFondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bone Marrow TransplantationDatabases, FactualAdultAgedAntineoplastic Combined Chemotherapy ProtocolsEuropeFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasms, Germ Cell and EmbryonalRetrospective StudiesSocieties, Medical

Identifiers

PMID28581469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.